Elevance Health Inc. faces market challenges due to Medicaid pressures and premium increases, leading to a 12% stock price drop and adjusted analyst outlook.

Elevance Health Inc. is set to announce its second-quarter 2025 earnings on July 17, with analysts expecting a 9.14% decrease in earnings per share compared to the previous year.

Elevance Health Inc. navigates a tumultuous year marked by financial fluctuations, legal challenges, and strategic moves, with a recent dividend announcement providing temporary relief to investors.